A Mechanistic Study on the Amiodarone-Induced Pulmonary Toxicity

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Al Shammari, Bader ^a   Khalifa, Mohamed ^b   Bakheet, Saleh A ^b   Yasser, Moustafa ^b  

^a Saudi Food and Drug Authority   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROLINE; KETONES; RATS; TOXICITY;

ENZYMATIC SYSTEM; HISTOPATHOLOGICAL DIAGNOSIS; INTERSTITIAL PNEUMONINITIDES; LEUKOCYTE COUNTS; MECHANISTIC STUDIES; PULMONARY TOXICITY; SPRAGUE-DAWLEY RATS; WEIGHT COEFFICIENTS;

BIOLOGICAL ORGANS;

ADENOSINE TRIPHOSPHATE; AMIODARONE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROXYPROLINE; LIPID PEROXIDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; MALONALDEHYDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; INTERSTITIAL PNEUMONIA; LEUKOCYTE COUNT; LUNG HOMOGENATE; LUNG LAVAGE; LUNG TOXICITY; LUNG WEIGHT; NONHUMAN; PROTEIN DEPLETION; RAT; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; LUNG; METABOLISM; ORGAN SIZE; PATHOLOGY; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATE; AMIODARONE; ANIMALS; BODY WEIGHT; GLUTATHIONE; HYDROXYPROLINE; LEUKOCYTE COUNT; LUNG; MALONDIALDEHYDE; NITRIC OXIDE; ORGAN SIZE; RATS, SPRAGUE-DAWLEY;

EID: 84962786860     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/6265853     Document Type: Article

References (39)

1. D. Chen and T. R. Hedges III, "Amiodarone optic neuropathy-review, " Seminars in Ophthalmology, vol. 18, no. 4, pp. 169-173, 2003.
2. E. A. Raeder, P. J. Podrid, and B. Lown, "Side effects and complications of amiodarone therapy, " American Heart Journal, vol. 109, no. 5, pp. 975-983, 1985.
3. J. W. Mason, "Amiodarone, " The New England Journal of Medicine, vol. 316, no. 8, pp. 455-466, 1987.
4. W. J. Martin II and E. C. Rosenow III, "Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2), " Chest, vol. 93, no. 6, pp. 1242-1246, 1988.
5. R. G. Leeder, J. F. Brien, and T. E. Massey, "Investigation of the role of oxidative stress in amiodarone-induced pulmonary toxicity in the hamster, " Canadian Journal of Physiology and Pharmacology, vol. 72, no. 6, pp. 613-621, 1994.
6. M. J. Reasor and S. Kacew, "An evaluation of possible mechanisms underlying amiodarone-induced pulmonary toxicity, " Proceedings of the Society for Experimental Biology and Medicine, vol. 212, no. 4, pp. 297-304, 1996.
7. T. L. Blake and M. J. Reasor, "Pulmonary responses to amiodarone in hamsters: comparison of intratracheal and oral administrations, " Toxicology andApplied Pharmacology, vol. 131, no. 2, pp. 325-331, 1995.
8. A. Matsui, H. Matsuo, H. Takanaga, S. Sasaki, M. Maeda, and Y. Sawada, "Prediction of catalepsies induced by amiodarone, aprindine and procaine: similarity in conformation of diethylaminoethyl side chain, " Journal of Pharmacology and Experimental Therapeutics, vol. 287, no. 2, pp. 725-732, 1998.
9. W. H. Chung, B. M. Bennett, W. J. Racz, J. F. Brien, and T. E. Massey, "Induction of c-jun and TGF-1 in Fischer 344 rats during amiodarone-induced pulmonary fibrosis, " American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 281, no. 5, pp. L1180-L1188, 2001.
10. R. Kannan, J. S. M. Sarma, M. Guha, and K. Venkataraman, "Tissue drug accumulation and ultrastructural changes during amiodarone administration in rats, " Toxicological Sciences, vol. 13, no. 4, pp. 793-803, 1989.
11. R. F. Henderson, "Use of bronchoalveolar lavage to detect respiratory tract toxicity of inhaledmaterial, " Experimental and Toxicologic Pathology, vol. 57, supplement 1, pp. 155-159, 2005.
12. B. M. Barbara and M. S. Stanley, "Preparation of mouse cell suspension, " in Selected Methods in Cellular Immunology, B. B. Mishell and S. M. Shiigi, Eds., pp. 3-27, W. H. Freeman and Co, San Francisco, Calif, USA, 1980.
13. Y. Chen, J. Chen, J. Dong, and Y. Jin, "Comparing study of the effect of nanosized silicon dioxide and microsized silicon dioxide on fibrogenesis in rats, " Toxicology and Industrial Health, vol. 20, no. 1-5, pp. 21-27, 2004.
14. H. Ohkawa, N. Ohishi, and K. Yagi, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, " Analytical Biochemistry, vol. 95, no. 2, pp. 351-358, 1979.
15. G. L. Ellman, "Tissue sulfhydryl groups, " Archives of Biochemistry and Biophysics, vol. 82, no. 1, pp. 70-77, 1959.
16. K. M. Miranda, M. G. Espey, and D. A. Wink, "A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite, " Nitric Oxide, vol. 5, no. 1, pp. 62-71, 2001.
17. D. E. Paglia and W. N. Valentine, "Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase, " The Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158-169, 1967.
18. C. P. Higgins, R. L. Baehner, J. McCallister, and L. A. Boxer, "Polymorphonuclear leukocyte species differences in the disposal of hydrogen peroxide (H2O2), " Proceedings of the Society for Experimental Biology and Medicine, vol. 158, no. 3, pp. 478-481, 1978.
19. J. M. McCord and I. Fridovich, "Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein), " The Journal of Biological Chemistry, vol. 244, no. 22, pp. 6049-6055, 1969.
20. H. E. Botker, H. H. Kimose, P. Helligso, and T. T. Nielsen, "Analytical evaluation of high energy phosphate determination by high performance liquid chromatography in myocardial tissue, " Journal ofMolecular and Cellular Cardiology, vol. 26, no. 1, pp. 41-48, 1994.
21. G. K. Reddy and C. S. Enwemeka, "A simplified method for the analysis of hydroxyproline in biological tissues, " Clinical Biochemistry, vol. 29, no. 3, pp. 225-229, 1996.
22. A. Vereckei, A. Blazovics, I. Gyorgy et al., "The role of free radicals in the pathogenesis of amiodarone toxicity, " Journal of Cardiovascular Electrophysiology, vol. 4, no. 2, pp. 161-177, 1993.
23. A. C. Nicolescu, J. L. Comeau, B. C. Hill et al., "Aryl radical involvement in amiodarone-induced pulmonary toxicity: investigation of protection by spin-trapping nitrones, " Toxicology and Applied Pharmacology, vol. 220, no. 1, pp. 60-71, 2007.
24. B. J. Day, "Antioxidants as potential therapeutics for lung fibrosis, " Antioxidants and Redox Signaling, vol. 10, no. 2, pp. 355-370, 2008.
25. R. B. Fox, J. R. Hoidal, D. M. Brown, and J. E. Repine, "Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factors and polymorphonuclear leukocytes, " American Review of Respiratory Disease, vol. 123, no. 5, pp. 521-523, 1981.
26. J. A. Leff, P. E. Parsons, C. E. Day et al., "Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis, " The Lancet, vol. 341, no. 8848, pp. 777-780, 1993.
27. J. F. Pittet, R. C. Mackersie, T. R. Martin, and M. A. Matthay, "Biological markers of acute lung injury: Prognostic and pathogenetic significance, " American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 4, pp. 1187-1205, 1997.
28. F. Chabot, J. A. Mitchell, J. M. C. Gutteridge, and T. W. Evans, "Reactive oxygen species in acute lung injury, " European Respiratory Journal, vol. 11, no. 3, pp. 745-757, 1998.
29. P. A. Ward and G. W. Hunninghake, "Lung inflammation and fibrosis, " American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 4, pp. S123-S129, 1998.
30. C. Sittipunt, K. P. Steinberg, J. T. Ruzinski et al., "Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome, "AmericanJournal of Respiratory andCritical Care Medicine, vol. 163, no. 2, pp. 503-510, 2001.
31. B. A. Freeman and J. D. Crapo, "Biology of disease: free radicals and tissue injury, " Laboratory Investigation, vol. 47, no. 5, pp. 412-426, 1982.
32. A. Siflinger-Birnboim and A. B. Malik, "Neutrophil adhesion to endothelial cells impairs the effects of catalase and glutathione in preventing endothelial injury, " Journal of Cellular Physiology, vol. 155, no. 2, pp. 234-239, 1993.
33. R. G. Eckenhoff, C. Dodia, Z. Tan, and A. B. Fisher, "Oxygendependent reperfusion injury in the isolated rat lung, " Journal of Applied Physiology, vol. 72, no. 4, pp. 1454-1460, 1992.
34. A. B. Al-Mehdi, G. Zhao, C. Dodia et al., "Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+, " Circulation Research, vol. 83, no. 7, pp. 730-737, 1998.
35. C. Li and R. M. Jackson, "Reactive species mechanisms of cellular hypoxia-reoxygenation injury, " American Journal of Physiology-Cell Physiology, vol. 282, no. 2, pp. C227-C241, 2002.
36. J. S. Beckman and W. H. Koppenol, "Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly, " The American Journal of Physiology, vol. 271, no. 5, pp. C1424-C1437, 1996.
37. A. van der Vliet, J. P. Eiserich, M. K. Shigenaga, and C. E. Cross, "Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease?" American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 1, pp. 1-9, 1999.
38. I. Fridovich, "Superoxide radical and superoxide dismutases, " Annual Review of Biochemistry, vol. 64, pp. 97-112, 1995.
39. Z. Vujaskovic, I. Batinic-Haberle, Z. N. Rabbani et al., "A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury, " Free Radical Biology and Medicine, vol. 33, no. 6, pp. 857-863, 2002.